Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Prescription Drug Prices
Teva Settles with Illinois AG in Medicaid Pricing Fraud Suit
In January 2019, Illinois Attorney General Lisa Madigan announced that her office settled with Teva Pharmaceuticals USA Inc., for…
CMS Issues Proposed Rule Focused on Part D and MA Drug Prices
On Monday, the Centers for Medicare and Medicaid Services (CMS) announced a proposed rule and opened comments that attempts to…
HHS Unveils New Plan for Prescription Prices for Medicare Part B Drugs
On Thursday, October 25, 2018, the United States Department of Health and Human Services (HHS) and the Centers for Medicare &…
Prescription Copays More Expensive Than Full Price?
A study published this year by the University of Southern California’s Schaeffer Center for Health Policy and Economics,…
Ohio Cracking Down on PBM Contracts
On Thursday, August 16, 2018, Ohio Auditor of State Dave Yost released findings from June that pharmacy benefit managers (PBMs)…
Congress and FDA address Over the Counter Drugs
On the evening of July 16, the House passed a sweeping over-the-counter (OTC) drug regulation reform bill, bringing the first…
2019 CMS Proposed Physician Fee Schedule Includes Serious Cuts to Medicare…
On July 12, the Centers for Medicare & Medicaid (CMS) released its proposed Medicare Physician Fee Schedule for 2019. The…
Is HHS Committed to Lowering Drug Prices?
On Tuesday, June 12, 2018, United States Health and Human Services (HHS) Secretary Alex Azar appeared before the United States…
Senate Holds Hearing on Pricing of Insulin
On Tuesday, May 8, 2018, the Senate Special Committee on Aging held a hearing entitled, “Insulin Access and Affordability: The…
Physician Specialty Groups Caution Against Proposed Drug Pricing Changes
Nine of the nation’s leading physician groups – including the American College of Rheumatology, American Academy of…